Profile
Catherine Lee Kelleher worked as a Medical Director-Clinical Research at Amgen, Inc. from 2008 to 2015.
She then worked as Head-Clinical Affairs at Proteus Digital Health, Inc. from 2015 to 2016.
Prior to that, she held senior positions in clinical development at ChemoCentryx, Inc., Coherus BioSciences, Inc., and Viking Therapeutics, Inc. From 1994 to 2008, she was an Associate Professor-Medicine at The University of Colorado School of Medicine.
Kelleher holds a doctorate from UW Medicine and an undergraduate degree from The Johns Hopkins University School of Medicine.
Former positions of Catherine Lee Kelleher
| Companies | Position | End |
|---|---|---|
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 2014-12-31 |
| The University of Colorado School of Medicine | Corporate Officer/Principal | 2007-12-31 |
| CHEMOCENTRYX, INC. | Chief Tech/Sci/R&D Officer | - |
| COHERUS BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Catherine Lee Kelleher
| UW Medicine | Doctorate Degree |
| The Johns Hopkins University School of Medicine | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| VIKING THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Catherine Lee Kelleher
